Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
The importance of nutrition and physical activity for cancer patients and their caregivers
It is well known that a healthy diet and physical activity are beneficial to cancer…
Unhealthy gut sets stage for breast cancer to spread
An unhealthy gut triggers changes in normal breast tissue that helps breast cancer spread to…
Incarceration associated with higher cancer mortality
New research from Yale Cancer Center, USA, reveals a higher risk of cancer mortality in…
Researchers develop model to predict prostate cancer aggressiveness
- ASCO 2020: Apalutamide significantly improved overall survival in patients with non-metastatic castration-resistant prostate cancer
- ASCO 2020: New class of targeted radioactive treatment effective for men with metastatic prostate cancer
- Novel radiotracer meets gold standard for imaging prostate cancer
Targeted treatment shrinks deadly paediatric brain tumours
Chemotherapy and radiation are effective cancer treatments because they kill rapidly dividing cells, including tumour cells. But for children, whose…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.